1
|
Noguez Imm R, Muñoz-Benitez J, Medina D, Barcenas E, Molero-Castillo G, Reyes-Ortega P, Hughes-Cano JA, Medrano-Gracia L, Miranda-Anaya M, Rojas-Piloni G, Quiroz-Mercado H, Hernández-Zimbrón LF, Fajardo-Cruz ED, Ferreyra-Severo E, García-Franco R, Rubio Mijangos JF, López-Star E, García-Roa M, Lansingh VC, Thébault SC. Preventable risk factors for type 2 diabetes can be detected using noninvasive spontaneous electroretinogram signals. PLoS One 2023; 18:e0278388. [PMID: 36634073 PMCID: PMC9836271 DOI: 10.1371/journal.pone.0278388] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Accepted: 11/15/2022] [Indexed: 01/13/2023] Open
Abstract
Given the ever-increasing prevalence of type 2 diabetes and obesity, the pressure on global healthcare is expected to be colossal, especially in terms of blindness. Electroretinogram (ERG) has long been perceived as a first-use technique for diagnosing eye diseases, and some studies suggested its use for preventable risk factors of type 2 diabetes and thereby diabetic retinopathy (DR). Here, we show that in a non-evoked mode, ERG signals contain spontaneous oscillations that predict disease cases in rodent models of obesity and in people with overweight, obesity, and metabolic syndrome but not yet diabetes, using one single random forest-based model. Classification performance was both internally and externally validated, and correlation analysis showed that the spontaneous oscillations of the non-evoked ERG are altered before oscillatory potentials, which are the current gold-standard for early DR. Principal component and discriminant analysis suggested that the slow frequency (0.4-0.7 Hz) components are the main discriminators for our predictive model. In addition, we established that the optimal conditions to record these informative signals, are 5-minute duration recordings under daylight conditions, using any ERG sensors, including ones working with portative, non-mydriatic devices. Our study provides an early warning system with promising applications for prevention, monitoring and even the development of new therapies against type 2 diabetes.
Collapse
Affiliation(s)
- Ramsés Noguez Imm
- Instituto de Neurobiología y Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, Mexico
| | - Julio Muñoz-Benitez
- Facultad de Ingeniería, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México, Mexico
| | - Diego Medina
- Facultad de Ingeniería, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México, Mexico
| | - Everardo Barcenas
- Facultad de Ingeniería, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México, Mexico
| | - Guillermo Molero-Castillo
- Facultad de Ingeniería, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México, Mexico
| | - Pamela Reyes-Ortega
- Instituto de Neurobiología y Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, Mexico
| | - Jorge Armando Hughes-Cano
- Instituto de Neurobiología y Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, Mexico
| | | | - Manuel Miranda-Anaya
- Unidad Multidisciplinaria de Docencia e Investigación-Facultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, Mexico
| | - Gerardo Rojas-Piloni
- Instituto de Neurobiología y Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, Mexico
| | | | - Luis Fernando Hernández-Zimbrón
- Research Department, Asociación Para Evitar la Ceguera, Mexico City, Mexico
- Clínica de Salud Visual, Escuela Nacional de Estudios Superiores, Unidad León, Universidad Nacional Autonóma de México (UNAM), León, Guanajuato, Mexico
| | | | | | - Renata García-Franco
- Instituto de la Retina del Bajío (INDEREB), Prolongación Constituyentes 302 (Consultorios 410 y 411, torre 3, Hospital San José), El jacal, Santiago de Querétaro, Querétaro, Mexico
| | - Juan Fernando Rubio Mijangos
- Instituto Mexicano de Oftalmología (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, Santiago de Querétaro, Querétaro, Mexico
| | - Ellery López-Star
- Instituto Mexicano de Oftalmología (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, Santiago de Querétaro, Querétaro, Mexico
| | - Marlon García-Roa
- Instituto Mexicano de Oftalmología (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, Santiago de Querétaro, Querétaro, Mexico
| | - Van Charles Lansingh
- Instituto Mexicano de Oftalmología (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, Santiago de Querétaro, Querétaro, Mexico
| | - Stéphanie C. Thébault
- Instituto de Neurobiología y Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, Mexico
| |
Collapse
|